Header cover image

Indian (NIFTY) Clinical Research and Equipment Industry Analysis

UpdatedSep 20, 2024
DataAggregated Company Financials
Companies17
  • 7D-2.2%
  • 3M20.9%
  • 1Y37.3%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.2%, driven by declines in Indegene and Divi's Laboratories of 9.0% and 1.0%, respectively. Meanwhile, Tarsons Products actually outperformed within the industry, gaining 5.4% in the last week. This takes the industry's 12 month performance to a gain of 37%. Earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 20 Sep 2024₹2.3t₹247.6b₹26.3b48.7x86.5x9.2x
Sun, 18 Aug 2024₹1.9t₹205.3b₹23.8b37.1x78.3x9.1x
Tue, 16 Jul 2024₹1.8t₹202.0b₹23.9b38.1x75x8.9x
Thu, 13 Jun 2024₹1.7t₹194.5b₹21.5b34.2x80x8.9x
Sat, 11 May 2024₹1.4t₹168.0b₹18.7b29x74.9x8.3x
Mon, 08 Apr 2024₹1.4t₹168.5b₹18.6b28.6x76.7x8.5x
Wed, 06 Mar 2024₹1.3t₹168.5b₹18.6b32.2x72.5x8x
Fri, 02 Feb 2024₹1.4t₹166.7b₹19.0b31.6x74.1x8.4x
Sun, 31 Dec 2023₹1.4t₹155.9b₹18.1b21.6x78.2x9.1x
Tue, 28 Nov 2023₹1.4t₹155.9b₹18.1b22.6x77x8.9x
Thu, 26 Oct 2023₹1.3t₹156.1b₹19.8b23.1x64.3x8.2x
Sat, 23 Sep 2023₹1.4t₹154.7b₹19.7b24.6x70.4x9x
Mon, 21 Aug 2023₹1.4t₹154.7b₹19.7b26.6x70.2x8.9x
Wed, 19 Jul 2023₹1.4t₹156.5b₹23.0b30.7x59.1x8.7x
Fri, 16 Jun 2023₹1.3t₹157.2b₹23.0b28.2x57.8x8.5x
Sun, 14 May 2023₹1.2t₹163.0b₹28.6b33.7x43.3x7.6x
Tue, 11 Apr 2023₹1.1t₹159.5b₹28.4b32.2x38.6x6.9x
Thu, 09 Mar 2023₹1.1t₹159.5b₹28.4b31.4x37.4x6.7x
Sat, 04 Feb 2023₹1.1t₹166.4b₹34.5b26.9x31x6.4x
Mon, 02 Jan 2023₹1.2t₹164.9b₹34.5b30.9x35.5x7.4x
Wed, 30 Nov 2022₹1.2t₹164.9b₹34.5b29.9x35.4x7.4x
Fri, 28 Oct 2022₹1.3t₹164.1b₹36.1b34.8x35.6x7.8x
Sun, 25 Sep 2022₹1.3t₹162.5b₹35.7b37.3x35.7x7.9x
Tue, 23 Aug 2022₹1.3t₹162.6b₹35.8b36.7x35.5x7.8x
Thu, 21 Jul 2022₹1.3t₹158.3b₹34.2b33.6x38.8x8.4x
Sat, 18 Jun 2022₹1.2t₹158.3b₹34.2b31.2x35.6x7.7x
Mon, 16 May 2022₹1.4t₹149.7b₹30.1b32.9x47.4x9.5x
Wed, 13 Apr 2022₹1.5t₹148.3b₹29.4b38.6x52.7x10.4x
Fri, 11 Mar 2022₹1.5t₹148.3b₹29.4b35.3x50x9.9x
Sun, 06 Feb 2022₹1.5t₹138.5b₹24.5b38.6x60.5x10.7x
Tue, 04 Jan 2022₹1.6t₹137.8b₹24.6b33.3x64.7x11.5x
Thu, 02 Dec 2021₹1.6t₹137.6b₹24.4b30x66x11.7x
Sat, 30 Oct 2021₹1.7t₹132.2b₹22.7b23x73.1x12.6x
Mon, 27 Sep 2021₹1.7t₹131.1b₹22.9b23.8x73.7x12.9x
Price to Earnings Ratio

73.7x


Total Market Cap: ₹1.7tTotal Earnings: ₹22.9bTotal Revenue: ₹131.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Clinical Research and Equipment Industry Price to Earnings3Y Average 57.9x202220232024
Current Industry PE
  • Investors are optimistic on the Indian Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 86.5x which is higher than its 3-year average PE of 57.9x.
  • The industry is trading close to its 3-year average PS ratio of 8.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 4.6% per year over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Indian Clinical Research and Equipment compare with similar industries?

IN Market-0.71%
Healthcare-2.02%
Life Sciences-2.18%
Clinical Research and Equipment-2.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TARSONS Tarsons Products₹468.355.4%
+₹1.3b
-13.2%PE67.2x
INNOVACAP Innova Captab₹773.801.9%
+₹838.3m
n/aPE41.7x
539267 Samsrita Labs₹30.0366.8%
+₹178.1m
76.8%PB3.6x
540729 Vanta Bioscience₹46.069.3%
+₹24.6m
10.3%PS3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

530239

₹146.30

Suven Life Sciences

7D

-3.3%

1Y

105.4%

524394

₹568.90

Vimta Labs

7D

-11.3%

1Y

4.7%

540729

₹46.06

Vanta Bioscience

7D

9.3%

1Y

10.3%

INDGN

₹642.30

Indegene

7D

-9.0%

1Y

n/a

INNOVACAP

₹773.80

Innova Captab

7D

1.9%

1Y

n/a

SYNGENE

₹902.10

Syngene International

7D

-1.6%

1Y

16.0%

DCAL

₹182.56

Dishman Carbogen Amcis

7D

-9.2%

1Y

7.6%

AKUMS

₹841.15

Akums Drugs and Pharmaceuticals

7D

-7.6%

1Y

n/a

TARSONS

₹468.35

Tarsons Products

7D

5.4%

1Y

-13.2%

539267

₹30.03

Samsrita Labs

7D

66.8%

1Y

76.8%